Health Care - Biotechnology Open to everyone
Embed:
Loading Portfolio...
| id | rsymbol | Symbol | Current Price | Change (%) | Open | High | Low | Volume | Date Added | Cost per share | Quantity | Value | Value Weighting | Gain (%) | Gain ($) | Fair Value ($) | Note | Company | Exchange | Industry | Market Cap ($M) | Sales ($M) | Book Value | Debt to Equity | Yield | Payout | 10-Y Dividend Payout Range | Financial Strength | Profitability | Interest Coverage | 52-W Range | 1-W Change (%) | 4-W Change (%) | 52-W Change (%) | YTD Change (%) | Beta | Short Ratio | P/E | P/S | P/B | 10-Year P/E Range | 10-Year P/S Range | 10-Year P/B Range | PEG | 1-Year Revenue Growth Rate | 5-Year Revenue Growth Rate | 10-Year Revenue Growth Rate | 1-Year EBITDA Growth Rate | 5-Year EBITDA Growth Rate | 10-Year EBITDA Growth Rate | NCAV | Median PS Value | Graham Number | Peter Lynch Fair Value | Earnings Yield | Forward Rate of Return | Shiller P/E | EV/EBIT | EV/EBITDA | Predictability Rank | Operating Margin | Net Margin | Cash per Share | ROE | ROA | Altman Z Score | Piotroski F Score | Beneish M Score | EV/Sales |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 431358 | BIIB | BIIB | 235.24 | 2.62 (1.13%) | 230.87 | 235.40 | 229.35 | 826K | 11/19/2012 | 142.72 | 0 | 0.00 | 0% | 64.83% | 0.00 | Add | Biogen Idec Inc | NAS(USA) | Biotechnology | 55218.1 | 5639.54 | 29.46 | 0.17 | 0.00 | 0 | 65.4 | 73.6 | 265.1 | 126.39 238.83 |
3.7 | 14.09 | 78.69 | 60.72 | 0.84 | 183 | 37.31 | 9.96 | 7.98 | 11.73 50 |
2.8 10 |
1.27 10 |
3.07 | 12.3 | 14.1 | 21 | 25.2 | 12.2 | 0 | 3.96 | 192.19 | 47.23 | 0 | 3.60 | 1.17 | 90.71 | 27.78 | 23.34 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
33.60 | 25 | -6.19 | 19.8 | 13.6 | 14.07 | 5 | -2.78 | 0.1 | ||
| 431359 | GILD | GILD | 55.81 | 0.33 (0.59%) | 55.30 | 56.35 | 54.90 | 8.7M | 11/19/2012 | 37.26 | 0 | 0.00 | 0% | 49.79% | 0.00 | Add | Gilead Sciences Inc | NAS(USA) | Biotechnology | 84566.1 | 9951.7 | 6.11 | 1.13 | 0.00 | 0 | 58.1 | 69.4 | 11.1 | 24.12 58.07 |
-0.87 | 10.36 | 120.51 | 51.97 | 0.45 | 507 | 31.25 | 9.03 | 9.13 | 9.71 50 |
3.48 10 |
4.15 10 |
1.93 | 10 | 21.3 | 32.1 | 9.8 | 16.3 | 0 | 1.43 | 70.51 | 0 | 31.03 | 4.70 | 19.79 | 36.87 | 21.46 | 20.10 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
41.30 | 26.7 | -6.61 | 27.8 | 12.2 | 5.58 | 7 | -2.86 | -0.66 | ||
| 431360 | AMGN | AMGN | 105.91 | 0.29 (0.27%) | 105.10 | 106.17 | 104.37 | 2.4M | 11/19/2012 | 85.30 | 0 | 0.00 | 0% | 24.16% | 0.00 | Add | Amgen Inc | NAS(USA) | Biotechnology | 79212.5 | 17455 | 25.47 | 1.12 | 1.57 | 0.3 | 0.139 0.261 |
42.3 | 62.8 | 9.8 | 67.61 114.95 |
0.27 | 1.38 | 55.67 | 23.96 | 0.41 | 238 | 17.92 | 4.72 | 4.16 | 10.4 50 |
3.01 10 |
1.83 10 |
2.63 | 23 | 11.4 | 12.6 | 33.6 | 6.8 | 11.6 | 4.33 | 137.5 | 0 | 43.79 | 6.80 | 11.71 | 22.69 | 14.77 | 12.31 |
![]()
Back Testing Results: Average gain of all 2-Star stocks: 6% per year. % of Stocks that are in still loss if held for 10yrs: 16%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
32.30 | 25.2 | -14.93 | 22.8 | 8 | 2.38 | 5 | -3 | -0.14 | |
| 431361 | CELG | CELG | 122.58 | -1.06 (-0.86%) | 122.61 | 123.71 | 121.66 | 2.3M | 11/19/2012 | 74.89 | 0 | 0.00 | 0% | 63.68% | 0.00 | Add | Celgene Corporation | NAS(USA) | Biotechnology | 51573 | 5698.01 | 13.6 | 0.23 | 0.00 | 0 | 69.2 | 86.8 | 36.4 | 58.53 131.82 |
-1.87 | 3.64 | 75.34 | 56.21 | 0.5 | 174 | 37.17 | 9.75 | 9.01 | 24.36 50 |
5.36 10 |
3.09 10 |
0 | 28.8 | 27 | 37.2 | 40.1 | 0 | 0 | 2.02 | 185.66 | 9.64 | 0 | 3.70 | 1.31 | 136.15 | 27.09 | 23.55 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
31.70 | 26.4 | -5.11 | 25.6 | 12.4 | 7.3 | 5 | -2.82 | 0.14 | ||
| 431362 | SPPI | SPPI | 8.33 | -0.22 (-2.57%) | 8.52 | 8.58 | 8.29 | 582K | 11/19/2012 | 10.91 | 0 | 0.00 | 0% | -23.65% | 0.00 | Add | Spectrum Pharmaceuticals Inc | NAS(USA) | Biotechnology | 511.4 | 246.52 | 4.73 | 0 | 0.00 | 0 | 75.8 | 51.2 | 0 | 6.92 17.48 |
2.33 | 16.18 | -24.82 | -25.53 | 1.43 | 1222 | 11.63 | 2.14 | 1.76 | 7.25 50 |
0.67 10 |
0.55 10 |
0 | 12.8 | 53.2 | 69 | -10.1 | 0 | 0 | 1.25 | 27.76 | 5.22 | 0 | 12.00 | -0.42 | 0 | 8.3 | 6.77 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
29.80 | 35.3 | -1.3 | 33.2 | 18.7 | 2.17 | 4 | -2.53 | 0.28 | ||
| 431363 | VRTX | VRTX | 78.40 | -0.08 (-0.10%) | 77.50 | 78.46 | 76.73 | 859K | 11/19/2012 | 41.36 | 0 | 0.00 | 0% | 89.56% | 0.00 | Add | Vertex Pharmaceuticals | NAS(USA) | Biotechnology | 17426.6 | 1416.67 | 4.58 | 0.43 | 0.00 | 0 | 47.3 | 50.4 | 0.2 | 38.44 87.47 |
-1.37 | -3.27 | 22.33 | 87.11 | 0.31 | 293 | 130.60 | 11.83 | 17.14 | 26.62 50 |
4.47 10 |
1.92 10 |
0 | -18.1 | 81.1 | 14.2 | -227.8 | 0 | 0 | 0.55 | 103.36 | 0 | 0 | 0.00 | -1.78 | 0 | -31.99 | -34.63 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
0.20 | -7 | -2.01 | -10.7 | -3.9 | 4.52 | 2 | -3.93 | 0.44 | ||
| 431364 | ALXN | ALXN | 99.17 | -0.71 (-0.71%) | 98.83 | 99.71 | 98.05 | 685K | 11/19/2012 | 91.93 | 0 | 0.00 | 0% | 7.88% | 0.00 | Add | Alexion Pharmaceuticals, Inc. | NAS(USA) | Biotechnology | 19491.2 | 1228.32 | 10.1 | 0 | 0.00 | 0 | 76.9 | 82.6 | 72.7 | 81.82 119.54 |
-3.62 | 11.14 | 6.52 | 5.79 | 0.59 | 291 | 68.03 | 16.15 | 9.82 | 13.83 50 |
9.66 10 |
0.95 10 |
0.97 | 37.4 | 40.5 | 124.5 | 64.1 | 70.6 | 0 | 1.38 | 201.02 | 12.48 | 0 | 2.40 | 0.43 | 126.22 | 41.26 | 39.15 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
35.70 | 22.5 | 1.78 | 12.9 | 9.7 | 21.3 | 7 | -2.87 | 0.68 | ||
| 431365 | UTHR | UTHR | 66.35 | -1.26 (-1.86%) | 67.58 | 67.58 | 65.25 | 794K | 11/19/2012 | 50.88 | 0 | 0.00 | 0% | 30.4% | 0.00 | Add | United Therapeutics Corporation | NAS(USA) | Biotechnology | 3379.6 | 957 | 21.6 | 0.28 | 0.00 | 0 | 73.1 | 82.6 | 33.2 | 42.12 69.65 |
-4.08 | 4.95 | 55.5 | 24.2 | 0.95 | 843 | 11.79 | 3.66 | 3.07 | 8.83 50 |
2.83 10 |
0.88 10 |
0 | 33.9 | 31 | 33.6 | 18.8 | 0 | 0 | 2.09 | 164.44 | 50.75 | 0 | 13.80 | 0.94 | 32.03 | 7.26 | 6.78 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
46.00 | 33.2 | -1.26 | 28.1 | 18.7 | 6.06 | 7 | -3.02 | 0.21 | ||
| 431366 | EBS | EBS | 14.16 | -0.10 (-0.70%) | 14.24 | 14.24 | 13.94 | 71.9K | 11/19/2012 | 14.57 | 0 | 0.00 | 0% | -2.81% | 0.00 | Add | Emergent BioSolutions, Inc. | NYSE(USA) | Biotechnology | 515.1 | 274.68 | 12.29 | 0.13 | 0.00 | 0 | 78.8 | 52.9 | 10000 | 12.5 16.99 |
-2.75 | -8.59 | 2.83 | -11.72 | -0.18 | 509 | 23.15 | 1.88 | 1.15 | 5.57 37.43 |
0.81 4.34 |
0.92 4.01 |
2.8 | -8.4 | 5.8 | 10.4 | -32.4 | -2.7 | 0 | 2.23 | 15.33 | 11.58 | 0 | 6.50 | -3.62 | 15.55 | 15.32 | 10.60 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
10.60 | 8.3 | 0.53 | 5.3 | 4.2 | 4.69 | 4 | -1.92 | 0.29 | ||
| 431367 | REGN | REGN | 250.31 | -4.56 (-1.79%) | 253.60 | 254.69 | 246.22 | 677K | 11/19/2012 | 158.98 | 0 | 0.00 | 0% | 57.45% | 0.00 | Add | Regeneron Pharmaceuticals, Inc. | NAS(USA) | Biotechnology | 24968.6 | 1586.35 | 12.78 | 0.89 | 0.00 | 0 | 65.4 | 51.2 | 10.1 | 107.31 283.99 |
-6.24 | 18.84 | 92.98 | 46.32 | 1.07 | 531 | 34.60 | 19.37 | 19.59 | 9.83 50 |
2.07 10 |
1.42 10 |
27.4 | 122.4 | 32 | 25.2 | 0 | 0 | 0 | 5.29 | 167.31 | 39.74 | 0 | 2.30 | -0.48 | 20904.6 | 42.69 | 40.10 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
33.20 | 54.4 | -5.41 | 60.2 | 36.1 | 18.97 | 6 | -0.28 | -0.09 | ||
| 431368 | CBST | CBST | 55.49 | -0.54 (-0.96%) | 54.89 | 55.64 | 54.16 | 634K | 11/19/2012 | 40.48 | 0 | 0.00 | 0% | 37.08% | 0.00 | Add | Cubist Pharmaceuticals, Inc. | NAS(USA) | Biotechnology | 3653.51 | 944.6 | 15.26 | 0.79 | 0.00 | 0 | 50.4 | 76.9 | 7.9 | 36.73 56.54 |
12.08 | 20.26 | 39.04 | 31.96 | 0.58 | 825 | 33.56 | 4.82 | 3.64 | 5.59 50 |
1.98 10 |
1.91 10 |
1.82 | 1.9 | 16.6 | 48.5 | 28.2 | 18.1 | 0 | 1.41 | 66.64 | 19.45 | 35.47 | 5.90 | 23.95 | 35.81 | 16.97 | 14.39 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
25.60 | 16.6 | 0.53 | 15.6 | 8 | 3.75 | 5 | -2.74 | 0.64 | ||
| 431369 | MNTA | MNTA | 13.39 | 0.08 (0.60%) | 13.26 | 13.50 | 13.11 | 127K | 11/19/2012 | 11.04 | 0 | 0.00 | 0% | 21.29% | 0.00 | Add | Momenta Pharmaceuticals, Inc. | NAS(USA) | Biotechnology | 691.1 | 47.3 | 6.97 | 0 | 0.00 | 0 | 69.2 | 47.1 | 10000 | 10.05 17.09 |
2.76 | 3.72 | -2.83 | 13.57 | 1.25 | 1218 | 0.00 | 14.40 | 1.92 | 2.64 21.67 |
1.84 10 |
1.31 10 |
0 | -79.3 | 59.2 | 39.1 | -158 | 0 | 0 | 0.28 | 19.84 | 0 | 0 | 15.50 | 0.78 | 0 | -4.63 | -5.15 |
Not Rated
Top Ranked Predictable Companies
|
-94.00 | -91.8 | 5.69 | -16.3 | -14.4 | 9.82 | 2 | -1.5 | 7.2 | ||
| 431370 | ARQL | ARQL | 2.73 | -0.02 (-0.73%) | 2.77 | 2.77 | 2.70 | 130K | 11/19/2012 | 2.36 | 0 | 0.00 | 0% | 15.68% | 0.00 | Add | Arqule, Inc. | NAS(USA) | Biotechnology | 172.216 | 33.58 | 1.28 | 0 | 0.00 | 0 | 43.1 | 34.7 | 10000 | 1.98 6.98 |
-2.5 | -9 | -53.09 | -2.15 | 1.31 | 735 | 0.00 | 5.06 | 2.13 | 0.69 10 |
0.46 10 |
0 | -31.6 | 19.1 | -10.9 | 0 | -41.2 | 0 | 0.01 | 3.11 | 0 | 0 | 0.50 | -60.14 | 0 | -6.72 | -7.29 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
-31.30 | -29.9 | 0.42 | -13.4 | -8.1 | -2.02 | 2 | -3.36 | 2.31 | |||
| 431371 | SVNT | SVNT | 0.56 | -0.01 (-1.77%) | 0.58 | 0.59 | 0.54 | 625K | 11/19/2012 | 1.13 | 0 | 0.00 | 0% | -50.44% | 0.00 | Add | Savient Pharmaceuticals | NAS(USA) | Biotechnology | 43.5 | 19.18 | -1.89 | -20.86 | 0.00 | 0 | 11.5 | 22.3 | 0 | 0.48 2.95 |
-0.02 | -26.52 | -26.33 | -46.68 | 2.32 | 4676 | 0.00 | 2.00 | 0.00 | 4.87 50 |
1.01 10 |
0.74 10 |
0 | 64.7 | 47.5 | -32 | 0 | 2.4 | 0 | 0.04 | 1.97 | 0 | 0 | 15.70 | -183.22 | 271.4 | -1.83 | -1.84 |
![]()
Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
-660.80 | -656.5 | -2.21 | 0 | -99.3 | -12.64 | 2 | -4.27 | -6.6 | ||
| Summary | -0.37 (-0.68%) | 0.00 | 27.49% | 0.00 | 31.22 | 8.2 | 6.46 | 31.22 | 8.2 | 6.46 |



RSS